Trial sequence meta‐analysis can reject false‐positive result calculated from conventional meta‐analysis
Ren‐Pin Chen, Chao Chen, Jie‐Yu Yu, Xie‐Lin Huang, Meng‐tao Zhou, Zhi‐Ming Huang – 28 February 2014
Reply
Mauro Bernardi, Paolo Caraceni, Roberta J. Navickis, Mahlon M. Wilkes – 28 February 2014
Computerized physician order entry‐based system to prevent HBV reactivation in patients treated with biologic agents: The PRESCRIB project
Blanca Sampedro, Cándido Hernández‐López, José Ramón Ferrandiz, Aitziber Illaro, Emilio Fábrega, Antonio Cuadrado, Paula Iruzubieta, Susana Menéndez, Joaquín Cabezas, Javier Crespo – 28 February 2014 – Computerized physician order entry (CPOE) applications are widely used to prevent medical errors. In our center, a CPOE system has been in use since 2009 on both the inpatient and outpatient levels.
A 24‐week pegylated interferon alpha‐2b versus a 12‐week pegylated interferon alpha‐2b alone or with ribavirin for patients with acute hepatitis C
Chia‐Yen Dai, Wan‐Long Chuang, Ming‐Lung Yu – 28 February 2014
Late HDV RNA relapse after peginterferon alpha‐based therapy of chronic hepatitis delta
Benjamin Heidrich, Cihan Yurdaydın, Gökhan Kabaçam, Boris A. Ratsch, Kalliopi Zachou, Birgit Bremer, George N. Dalekos, Andreas Erhardt, Fehmi Tabak, Kendal Yalcin, Selim Gürel, Stefan Zeuzem, Markus Cornberg, C.‐Thomas Bock, Michael P. Manns, Heiner Wedemeyer, HIDIT‐1 Study Group – 28 February 2014 – Interferon alpha is the only treatment option for hepatitis delta virus (HDV). Trials investigating the efficacy of pegylated interferon alpha (PEG‐IFNa) showed HDV RNA negativity rates of 25‐30% 24 weeks after therapy.
Reply
Ju Dong Yang, Ayako Suzuki – 28 February 2014
Hypothesis of three liver grafts from a deceased whole liver
Cheng‐Yen Chen, Chinsu Liu – 26 February 2014
Segmental biliary duct N‐butyl cyanoacrylate ablation in a transplant liver for a biliary leak after hepaticojejunostomy
Mehrzad Zarghouni, Marco Cura, Peter T. W. Kim, Giuliano Testa, Goran B Klintmalm – 26 February 2014
Effect of the pretransplant serum sodium concentration on outcomes following liver transplantation
Michael D. Leise, Byung Cheol Yun, Joseph J. Larson, Joanne T. Benson, Ju Dong Yang, Terry M. Therneau, Charles B. Rosen, Julie K. Heimbach, Scott W. Biggins, W. Ray Kim – 25 February 2014 – Hyponatremia is associated with an increased risk of mortality on the liver transplantation (LT) waiting list. Although the incorporation of the serum sodium (Na) level into the Model for End‐Stage Liver Disease score may reduce wait‐list mortality, concerns remain about a potential association between pre‐LT hyponatremia and decreased post‐LT survival.
Reply
William Bernal, Julia Wendon – 25 February 2014